Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Can DMARD Doses Be Safely Reduced for RA Patients? Korean Trial Says Yes.

(MedPage Today) -- Close to 90% of patients with rheumatoid arthritis (RA) well controlled on targeted therapies were able to take 50% dosage reductions without experiencing worsened disease activity in a randomized trial, South Korean researchers...

Can DMARD Doses Be Safely Reduced for RA Patients? Korean Trial Says Yes.

We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.

Read the original at medpagetoday.com →

More in Health & Medicine

Silicon Valley billionaires are obsessed with 'reprogramming' their bodies for longevity. The first human trial suggests they may be onto something.

The first humans are trying out cellular reprogramming for longevity. It looks like it might be working.

  • Silicon Valley billionaires invest in longevity through cellular reprogramming.
  • First human trial at Life Biosciences rejuvenates glaucoma patients' eyesight.
  • No major side effects reported; vision improved for two out of three patients.

More from Thursday 8 October →